You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
About Kedrion - Front Image

kedrion eurobond

Maturity 24th April 2019 - XS1061608300

On April 16th, Kedrion Group S.p.A. successfully completed the issuance of a 300 million euro senior, unsecured and unrated debenture loan, which will be due April 2019. They are fixed-rate securities with a 4.625% coupon p.a.. Issue price is at par (100%). With a minimum denomination of 100,000 euros, such bonds have been placed with leading international institutional investors and have been listed on the Irish Stock Exchange by the date of accrual, April 24th 2014.

Bond Quotes


Audited financial statements 2016

Kedrion’s shareholders meeting approved the 2016 stand-alone Financial Statements and acknowledged the 2016 Consolidated FS

read more 

Annual Results 2016

Consolidated turnover of 659.3 million Euro, a growth of 89 million Euro or 15.6%

read more 

Kedrion Biopharma strengthens its position on the US market

Granted exclusive rights to commercialize a lifesaving drug in the US

read more 
For more information please contact: